BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 11218386)

  • 1. [Two cases of typhoid fever with reduced susceptibility to fluoroquinolones].
    Adachi T; Masuda G; Imamura A; Ajisawa A; Negishi M; Takayama N; Takinaga K; Takano S
    Kansenshogaku Zasshi; 2001 Jan; 75(1):48-52. PubMed ID: 11218386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suboptimal clinical response to ciprofloxacin in patients with enteric fever due to Salmonella spp. with reduced fluoroquinolone susceptibility: a case series.
    Slinger R; Desjardins M; McCarthy AE; Ramotar K; Jessamine P; Guibord C; Toye B
    BMC Infect Dis; 2004 Sep; 4():36. PubMed ID: 15380025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reevaluating fluoroquinolone breakpoints for Salmonella enterica serotype Typhi and for non-Typhi salmonellae.
    Crump JA; Barrett TJ; Nelson JT; Angulo FJ
    Clin Infect Dis; 2003 Jul; 37(1):75-81. PubMed ID: 12830411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of treatment regimens for Typhoid fever in the nalidixic acid-resistant S. typhi (NARST) era in South India.
    Bandyopadhyay R; Balaji V; Yadav B; Jasmine S; Sathyendra S; Rupali P
    Trop Doct; 2018 Jul; 48(3):182-188. PubMed ID: 29495943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emergence of multidrug-resistant Salmonella typhi in rural southern India.
    Rao PS; Rajashekar V; Varghese GK; Shivananda PG
    Am J Trop Med Hyg; 1993 Jan; 48(1):108-11. PubMed ID: 8427378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative in vitro activity of enoxacin and other fluoroquinolones against multi-resistant strains of Salmonella typhi.
    Hannan A
    Curr Med Res Opin; 1992; 12(9):560-3. PubMed ID: 1316257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment failure in a typhoid patient infected with nalidixic acid resistant S. enterica serovar Typhi with reduced susceptibility to ciprofloxacin: a case report from Cameroon.
    Nkemngu NJ; Asonganyi ED; Njunda AL
    BMC Infect Dis; 2005 Jun; 5():49. PubMed ID: 15969764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluoroquinolones in the treatment of typhoid fever and the carrier state.
    Zavala Trujillo I; Quiroz C; Gutierrez MA; Arias J; Renteria M
    Eur J Clin Microbiol Infect Dis; 1991 Apr; 10(4):334-41. PubMed ID: 1864294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quinolones in Salmonella typhi infection.
    DuPont HL
    Drugs; 1993; 45 Suppl 3():119-24. PubMed ID: 7689442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short course quinolone therapy of typhoid fever in developing countries.
    Limson BM
    Drugs; 1995; 49 Suppl 2():136-8. PubMed ID: 8549283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcomes in typhoid fever: adverse impact of infection with nalidixic acid-resistant Salmonella typhi.
    Kadhiravan T; Wig N; Kapil A; Kabra SK; Renuka K; Misra A
    BMC Infect Dis; 2005 May; 5():37. PubMed ID: 15904505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnostic difficulties in febrile travellers returning from the tropics. Two cases of typhoid fever imported from India].
    Kacprzak E; Stefaniak J; Skoryna-Karcz B; Wojtacha A; Bolewska B; Juszczyk J
    Pol Merkur Lekarski; 2002 Dec; 13(78):509-15. PubMed ID: 12666454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Salmonella of Indian origin: pseudo-susceptibility to fluoroquinolones].
    Denes E; Gondran G; Bezanahary H; Genet C; Rogez JP; Weinbreck P; Martin C
    Med Mal Infect; 2005 Apr; 35(4):223-4. PubMed ID: 15914292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and bacteriological profiles of patients with typhoid fever treated during 1975-1998 in the Tokyo Metropolitan Komagome Hospital.
    Hoshino Y; Masuda G; Negishi M; Ajisawa A; Imamura A; Hachimori K; Takayama N; Yamaguchi T; Kimura M
    Microbiol Immunol; 2000; 44(7):577-83. PubMed ID: 10981830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Typhoid fever: narrowing therapeutic options in India.
    Capoor MR; Nair D; Hasan AS; Aggarwal P; Gupta B
    Southeast Asian J Trop Med Public Health; 2006 Nov; 37(6):1170-4. PubMed ID: 17333772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of typhoid fever with tosufloxacin].
    Ohnishi K; Murata M; Ajima I; Saku K; Nakamura A
    Kansenshogaku Zasshi; 1992 Sep; 66(9):1295-6. PubMed ID: 1431392
    [No Abstract]   [Full Text] [Related]  

  • 17. Typhoid fever in the United States, 1985-1994: changing risks of international travel and increasing antimicrobial resistance.
    Mermin JH; Townes JM; Gerber M; Dolan N; Mintz ED; Tauxe RV
    Arch Intern Med; 1998 Mar; 158(6):633-8. PubMed ID: 9521228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluoroquinolone resistance in Salmonella Typhi.
    Cooke FJ; Wain J; Threlfall EJ
    BMJ; 2006 Aug; 333(7563):353-4. PubMed ID: 16902221
    [No Abstract]   [Full Text] [Related]  

  • 19. Quinolones in the treatment of typhoid fever.
    Akalin HE
    Drugs; 1999; 58 Suppl 2():52-4. PubMed ID: 10553706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Typhoid fevers: treatment with lomefloxacin.
    Hafiz S; Habib F; Ahmad N; Haq I; Husain R
    J Pak Med Assoc; 1998 Jun; 48(6):168-70. PubMed ID: 9813988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.